Communiqués CellaVision AB OTC Markets

Actions

CLVSF

SE0000683484

Equipement et technologie médicale avancés

Temps Différé OTC Markets Autres places de cotation 18:52:56 23/06/2026			Varia. 5j.	Varia. 1 janv.
14,00 ^USD	+3,78%		-.--%	-16,80%

11:13	Case All Star Småbolag recule de 4,20 % en juin - participation à l'introduction en bourse de Savox	FW
24/06	Danske Bank abaisse l’objectif de cours de Cellavision à 180 couronnes (185) et réitère sa recommandation d’achat - BN	FW

Communiqués

03/07	Invitation to Presentation of the CellaVision Report for the Second Quarter 2026 on July 17, at 11:00 CEST	AQ
05/06	The Board of CellaVision AB appoints Steve Ferguson as CEO	AQ
28/04	Bulletin from the Annual General Meeting of CellaVision AB (publ)	AQ
24/04	Softer quarter due to lower sales in EMEA	AQ
21/04	CellaVision – Consensus estimates Q1 2026	AQ
16/04	The Nomination Committee’s proposals for the 2026 Annual General Meeting of CellaVision AB	AQ
10/04	Invitation to Presentation of the CellaVision Report for the First Quarter 2026 on April 24, at 11:00 CEST	AQ
01/04	CellaVision publishes its 2025 Annual and Sustainability Report	AQ
25/03	NOTICE OF ANNUAL GENERAL MEETING IN CELLAVISION AB (publ)	AQ
11/03	The new CellaVision® Bone Marrow Aspirate Application launches in EMEA	AQ
05/02	Solid Quarter driven by Strong Performance in Americas	AQ
02/02	CellaVision – Consensus estimates Q4 2025	AQ
22/01	Invitation to Presentation of the CellaVision Year-end Report 2025 on February 5, at 11:00 CET	AQ
12/12	CellaVision appoints Monica Jönsson as new CFO	AQ
08/12	CellaVision receives CE marking according to IVDR Class C for CellaVision® Bone Marrow Aspirate Application	AQ
06/11	Softer Quarter with Mixed Regional Performance	AQ
03/11	CellaVision – Consensus estimates Q3 2025	AQ
23/10/25	Invitation to Presentation of the CellaVision Report for the Third Quarter 2025 on November 6, at 11:00 CET	AQ
21/10/25	Nomination Committee for the CellaVision Annual General Meeting 2026	AQ
02/09/25	CellaVision : appoints Monica Jönsson as Interim CFO	PU
22/07/25	Cellavision Q2 2025 - Stable with Decent Growth	AQ
18/07/25	Robust Result with Mixed Regional Performance	AQ
15/07/25	CellaVision – Consensus estimates Q2 2025	AQ
04/07/25	Invitation to Presentation of the CellaVision Report for the Second Quarter 2025 on July 18, at 11:00 CEST	AQ
14/05/25	CellaVision AB announces change in management team	AQ